Publications by authors named "Mathieu Coudert"

Claim this Profile
C
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Tadej Battelino, Thomas Danne, Steve V Edelman, Pratik Choudhary, Eric Renard, Mathieu Coudert

Diabetes Obes Metab· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
Mohamed Hassanein, Rachid Malek, Inass Shaltout, Rakesh Kumar Sahay, Mehmet Akif Buyukbese, Mathieu Coudert

Diabetes Metab Syndr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study.
Rory J McCrimmon, Alice Y Y Cheng, Gagik Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert

Diabetes Obes Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
William H Polonsky, Francesco Giorgino, Julio Rosenstock, Katherine Whitmire, Elisheva Lew, Mathieu Coudert

Diabetes Obes Metab· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study.
Gagik R Galstyan, Amir Tirosh, Hernando Vargas-Uricoechea, Maria Aileen Mabunay, Mathieu Coudert

Diabetes Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
Rory J McCrimmon, Saud Al Sifri, Rifat Emral, Viswanathan Mohan, Leobardo Sauque-Reyna, Mathieu Coudert

Diabetes Obes Metab· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control.
John Anderson, Luigi Meneghini, Debbie Hinnen, Jasvinder Gill, Mathieu Coudert

J Diabetes Complications· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial.
Rakesh Sahay, Khadijah Hafidh, Khier Djaballah, Mathieu Coudert, Sami Azar

Diabetes Res Clin Pract· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.
Christophe Borg, Georges Mantion, Frank Boudghène, Françoise Mornex, François Ghiringhelli, Mathieu Coudert

Clin Colorectal Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world anaplastic lymphoma kinase (ALK) rearrangement testing patterns, treatment sequences, and survival of ALK inhibitor-treated patients.
Jessica Davies, Michael Martinec, Mathieu Coudert, Paul Delmar, Gracy Crane

Curr Med Res Opin· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib.
Jessica Davies, Michael Martinec, Paul Delmar, Mathieu Coudert, Walter Bordogna

J Comp Eff Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE).
Jaafar Bennouna, Lionel Falchero, Roland Schott, Franck Bonnetain, Mathieu Coudert

Oncology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the use of tocilizumab as monotherapy in patients with rheumatoid arthritis in a real-life setting: results at 1 year of the ACT-SOLO study.
René-Marc Flipo, Jean-Francis Maillefert, Pascal Chazerain, Isabelle Idier, Mathieu Coudert

RMD Open· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Bruno Coudert, Jean-Yves Pierga, Marie-Ange Mouret-Reynier, Kaldoun Kerrou, Jean-Marc Ferrero, Mathieu Coudert

Lancet Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Generic drugs at hospital discharge: assessment in geriatrics].
Hugues Michelon, Julie Marcel, Mathieu Coudert, Kim Juillard, Laurence Pochat

Geriatr Psychol Neuropsychiatr Vieil· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study.
Raphaële Renard-Penna, Morgan Rouprêt, Eva Comperat, Amine Ayed, Mathieu Coudert

Urol Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain dynamic neurochemical changes in dystonic patients: a magnetic resonance spectroscopy study.
Malgorzata Marjańska, Stéphane Lehéricy, Romain Valabrègue, Traian Popa, Yulia Worbe, Mathieu Coudert

Mov Disord· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a short food frequency questionnaire to evaluate nutritional lifestyles in hypercholesterolemic patients.
Sophie Béliard, Mathieu Coudert, René Valéro, Laurie Charbonnier, Emilie Duchêne

Ann Endocrinol (Paris)· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.
Lucile Mercadal, Mathieu Coudert, Anne Vassault, Laurence Pieroni, Alain Debure

Clin J Am Soc Nephrol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.
Anne Bachelot, Zeina Chakhtoura, Geneviève Plu-Bureau, Mathieu Coudert, Christiane Coussieu

Eur J Endocrinol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients.
Alain Gautier, Ariane Godbout, Catherine Grosheny, Isabelle Tejedor, Mathieu Coudert

J Clin Endocrinol Metab· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
Ivan Berlin, Nelly Jacob, Mathieu Coudert, Jean Perriot, Laurette Schultz

Addiction· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression comorbidity in spinocerebellar ataxia.
Tanja Schmitz-Hübsch, Mathieu Coudert, Sophie Tezenas du Montcel, Paola Giunti, Robyn Labrum

Mov Disord· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the threat of a disulfiram-ethanol reaction on cue reactivity in alcoholics.
Marilyn D Skinner, Mathieu Coudert, Ivan Berlin, Elodie Passeri, Laurent Michel

Drug Alcohol Depend· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.
Tanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, Christoph Globas, Laszlo Baliko

Mov Disord· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis